Despite these limitations, the analysis of breast cancers and renal cancers clearly indicate a correlative link between high TEX19 expression and poor prognosis, consistent with a functional role for TEX19 as an oncogenic proliferative driver. The gene discussed is TEX19; the disease is breast carcinoma.